Teriparatide biosimilar (Wuxi Hebang)
特立帕肽生物类似药（无锡和邦）
Report date: 2025/03/03 15:25:40
Base Information
Drug NameTeriparatide biosimilar (Wuxi Hebang)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuxi Hebang Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesWuxi Hebang Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A